Absence of hSNF5/INI1 mutation in human lung cancer

Cancer Letters

Volumn 153, Issue 1-2, 2000, Pages 57-61

  Manda, Ryokuhei ^a,b   Kohno, Takashi ^a   Hamada, Kunihiro ^b   Takenoshita, Seiichi ^c   Kuwano, Hiroyuki ^b   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

hSNF5 INI1 gene; Lung cancer; Mutation; Polymorphisms

Indexed keywords

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMOSOME 22Q; GENE DELETION; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EXONS; GENE FREQUENCY; HUMANS; INTRONS; LUNG NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034729309     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00342-6     Document Type: Article

References (12)

1. Kohno T., Yokota J. How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis. 20:1999;1403-1410.
2. Testa J.R., Liu Z., Feder M., Bell D.W., Balsara B., Cheng J.Q., Taguchi T. Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet. Cytogenet. 95:1997;20-32.
3. Kawanishi M., Kohno T., Otsuka T., Adachi J., Sone S., Noguchi M., Hirohashi S., Yokota J. Allelotype and replication error phenotype of small cell lung carcinoma. Carcinogenesis. 18:1997;2057-2062.
4. Shiseki M., Kohno T., Nishikawa R., Sameshima Y., Mizoguchi H., Yokota J. Frequent allelic losses on chromosomes 2q. 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res. 54:1994;5643-5648.
5. Versteege I., Sevenet N., Lange J., Rousseau-Merck M.F., Ambros P., Handgretinger R., Aurias A., Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 394:1998;203-206.
6. Biegel J.A., Zhou J.Y., Rorke L.B., Stenstrom C., Wainwright L.M., Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and habdoid tumors. Cancer Res. 59:1999;74-79.
7. Kukita Y., Tahira T., Sommer S.S., Hayashi K. SSCP analysis of long DNA fragments in low pH gel. Hum. Mutat. 10:1997;400-407.
8. Iida A., Kurose K., Isobe R., Akiyama F., Sakamoto G., Yoshimoto M., Kasumi F., Nakamura Y., Emi M. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer. 21:1998;108-112.
9. Allione F., Eisinger F., Parc P., Noguchi T., Sobol H., Birnbaum D. Loss of heterozygosity at loci from chromosome arm 22Q in human sporadic breast carcinomas. Int. J. Cancer. 75:1998;181-186.
10. Rouleau G.A., Merel P., Lutchman M., Sanson M., Zucman J., Marineau C., Hoang-Xuan K., Demczuk S., Desmaze C., Plougastel B., Pulst S.M., Lenoir G., Bijlsma E., Fashold R., Dumanski J., Jong P., Parry D., Eldrige R., Aurias A., Delattre O., Thomas G. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 363:1993;515-521.
11. Trofatter J.A., MacCollin M.M., Rutter J.L., Murrell J.R., Duyao M.P., Parry D.M., Eldridge R., Kley N., Menon A.G., Pulaski K., Haase V.H., Ambrose C.M., Munroe D., Bove C., Haines J.L., Martuza R.L., MacDonald M.E., Seizinger B.R., Short M.P., Buckler A.J., Gusella J.F. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 72:1993;791-800.
12. Sekido Y., Pass H.I., Bader S., Mew D.J., Christman M.F., Gazdar A.F., Minna J.D. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res. 55:1995;1227-1231.